Neuroone Medical Technologies (NMTC) Gross Margin (2011 - 2026)
Neuroone Medical Technologies (NMTC) posted Gross Margin of 53.18% for Q1 2026, down 1.88% on a QoQ basis from 54.2% in Q4 2025, and down 243.0% year-over-year from 37.19% in Q1 2025.
Neuroone Medical Technologies (NMTC) Gross Margin (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies' Gross Margin history runs 11 years deep, the most recent figure standing at 53.18% for Q1 2026.
- Quarterly Gross Margin fell 243.0% year-over-year to 53.18% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 54.41% (up 22.0% YoY) and the FY2025 annual result came in at 56.51%, up 2525.0% from the prior year.
- Gross Margin was 53.18% for Q1 2026 at Neuroone Medical Technologies, down from 54.2% in the prior quarter.
- Across five years, Gross Margin topped out at 58.85% in Q4 2024 and bottomed at 99.01% in Q1 2022.
- A 5-year average of 23.12% and a median of 34.13% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin soared 10577 bps — and 2025, when it sank 465 bps.
- Neuroone Medical Technologies' Gross Margin stood at 10.74% in 2022, then soared by 354 bps to 27.24% in 2023, then soared by 116 bps to 58.85% in 2024, then fell by 8 bps to 54.2% in 2025, then slipped by 2 bps to 53.18% in 2026.
- Business Quant data shows NMTC's Gross Margin at 53.18% in Q1 2026, 54.2% in Q4 2025, and 55.77% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 53.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.18% |
| Dec 31, 2025 | 54.20% |
| Sep 30, 2025 | 55.77% |
| Jun 30, 2025 | 53.94% |
| Mar 31, 2025 | 55.61% |
| Dec 31, 2024 | 58.85% |
| Sep 30, 2024 | 51.81% |
| Jun 30, 2024 | 34.13% |
| Mar 31, 2024 | 28.35% |
| Dec 31, 2023 | 27.24% |
| Sep 30, 2023 | 26.11% |
| Jun 30, 2023 | 38.68% |
| Mar 31, 2023 | 6.76% |
| Dec 31, 2022 | -10.74% |
| Sep 30, 2022 | -21.90% |
| Jun 30, 2022 | -20.01% |
| Mar 31, 2022 | -99.01% |
| Dec 31, 2021 | -38.81% |
| Sep 30, 2021 | -35.44% |
| Jun 30, 2021 | -54.47% |